Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

TINTIN

Financiado

Cerrado

Training in neurodegeneration therapeutics intervention and neurorepair

Dopamine neurons play a central role in major illnesses, such as anxiety and mood disorders, schizophrenia, autism-spectrum disorders, Parkinson’s disease, epilepsy, and dementia. A multidisciplinary approach must be taken by Euro... ver más

30/09/2017

TRINITY COLLEGE DU...

4M€

Presupuesto del proyecto: 4M€

Líder del proyecto

THE PROVOST FELLOWS FOUNDATION SCHOLARS THE... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 8 Participantes

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2017-09-30 No tenemos la información de la convocatoria

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

8 Participantes

TRINITY COLLEGE DUBLIN

0.00€ | Lider

UNIVERSITY COLLEGE LONDON

N.D. | Participante

NIBRT

N.D. | Participante

USAL

N.D. | Participante

Proyectos interesantes

EuroNeurotrophin

Medical Technol...

Data Science

4M€ Cerrado

NeuronAgeScreen

Medical Technol...

Data Science

150K€ Cerrado

SPARK

Medical Technol...

Data Science

189K€ Cerrado

FutureTrophicFactors

Medical Technol...

Data Science

1M€ Cerrado

NEUROMODEL

Medical Technol...

Data Science

3M€ Cerrado

PARTHECOM

Medical Technol...

Data Science

216K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

THE PROVOST FELLOWS FOUNDATION SCHOLARS THE... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 4M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Dopamine neurons play a central role in major illnesses, such as anxiety and mood disorders, schizophrenia, autism-spectrum disorders, Parkinson’s disease, epilepsy, and dementia. A multidisciplinary approach must be taken by European researchers to discover the molecular basis of dopamine neurodegeneration and how new technologies will lead to repair and regeneration of neuronal systems in the brain. The TINTIN proposal describes how early stage researchers (ESRs) and experienced researchers (ERs) will undertake advanced research training projects on metabolism and autophagy in neurons, induced pluripotent stem cells and neurorepair systems. Parallel research projects will involve computational modelling of metabolism in the dopamine neuron and the in silico design of novel therapeutics that are selectively transported into the dopamine neuron. This fundamental training and research will be merged with new cutting edge glycan based biomarker technologies, drug simulation and computational/mathematical models of dopaminergic neurons. TINTIN will train young researchers by merging key research groups in 7 Universities and 8 industry/SME partners from Western Europe (Ireland, UK) across central and Southern Europe (Denmark, Germany, Austria, Italy, Spain) and Eastern Europe (Turkey). The secondments of ESRs and ERs into and out of 8 commercial partners in the area of glycan discovery and drug design will ensure that researchers receive intensive training in emerging research areas in neurotherapeutic development as well as key information in how to commercialize such innovation and discovery. The breadth of the aims, techniques and knowledge of TINTIN, the academic basis, the integrating of ESRs and ERs into industry, the potential for transfer to the European pharmaceutical industry, and enrichment of scientific training across Europe all fit the ITN model.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores